2022 Best Practices Recognition
Implantica
European Gastroesophageal Reflux Disease Therapy Device
Technology Innovation Leadership Award
Award Recognition
Frost & Sullivan reserves this recognition for companies at the innovation and growth forefront of their respective industries.
Implantica Applauded by Frost & Sullivan for Transforming Gastroesophageal Reflux Disease Treatment with Its Revolutionary Implant RefluxStop™
The RefluxStop™ device prevents the regurgitation of stomach fluid into the esophagus and addresses the limitations of proton pump inhibitors (PPIs) and existing surgical methods and devices for treating acid reflux disease.
